NTRK3 and breast cancer: Dendritic cells, CD4+ T cells, and CD8+ T cells play crucial roles in initiating and sustaining anti-tumor immunity, suggesting that NTRK3 may enhance immune surveillance and contribute to a more favorable immune landscape in BC [5].